CAUSES OF THYROTOXICOSIS WITH INCREASED THYROID SECRETION Graves

  • Slides: 51
Download presentation

CAUSES OF THYROTOXICOSIS WITH INCREASED THYROID SECRETION • • • Graves disease Toxic nodular

CAUSES OF THYROTOXICOSIS WITH INCREASED THYROID SECRETION • • • Graves disease Toxic nodular goitre Toxic thyroid adenoma Jod basedows hyperthyroidism Secondary hyperthroidism due to TSH Thyroiditis WITHOUT INCREASED THYROID SECRETION • • Factitious hyperthyyroidism Struma ovarii Molar pregnancy Rare metastatic thyroid ca.

PRIMARY THYROTOXICOSIS • The goitre is diffuse and vascular, large or small, firm or

PRIMARY THYROTOXICOSIS • The goitre is diffuse and vascular, large or small, firm or soft, • Thrill and a bruit may be present. • The onset is abrupt. • Hyperthyroidism is usually more severethan in secondary thyrotoxicosis but cardiac failure is rare. . SECONDARY THYROTOXICOSIS • the goitre is nodular. • The onset is insidious • may present with cardiac failure or atrial fibrillation. • hyperthyroidism is not severe. • Eye signs other than lid lag and lid spasm (due to hyperthyroidism) are very rare.

PRIMARY THYROTOXICOSIS

PRIMARY THYROTOXICOSIS

GRAVES DISEASE q. The commonest form of thyrotoxicosis q More prevalent in young adults

GRAVES DISEASE q. The commonest form of thyrotoxicosis q More prevalent in young adults q 6 times more

HISTORY Caleb Parry(Welsh phy. )- first described (1825) Named after Robert Graves(1835)

HISTORY Caleb Parry(Welsh phy. )- first described (1825) Named after Robert Graves(1835)

AETIOLOGY • • Genetic factors Association with other autoimmune diseases • Association with HLA

AETIOLOGY • • Genetic factors Association with other autoimmune diseases • Association with HLA DR 3, B 8, BW 35, BW 46 • Emotional uphaevals • Consumption of iodine excess Use of thyroid hormone

PATHOLOGY & PATHOGENESIS • Autoimmune disorder • Thyroid stimulating Igs produced against antigen in

PATHOLOGY & PATHOGENESIS • Autoimmune disorder • Thyroid stimulating Igs produced against antigen in thyroid • Appear to be directed against TSH receptors TRAbs

THEORIES • Defect in suppresssor Tcells-allows helper T cells to stimulate TSI from B

THEORIES • Defect in suppresssor Tcells-allows helper T cells to stimulate TSI from B cells • Another theory is that an immune response is launched to altered antigens on the follicular cell surface

PATHOLOGY MACROSCOPY • Diffuse and smoothly enlarged • Vascularity incresed

PATHOLOGY MACROSCOPY • Diffuse and smoothly enlarged • Vascularity incresed

MICROSCOPY • Hyperplastic columnar epithelium, pappilary projections. • Nuclei exhibit mitosis • Aggregates of

MICROSCOPY • Hyperplastic columnar epithelium, pappilary projections. • Nuclei exhibit mitosis • Aggregates of lymphoid tissue • Vascularity increased • Minimal colloid

CLINICAL FEATURES • • • Heat intolerance Increased thirst Sweating Weight loss Menustrual irregularities

CLINICAL FEATURES • • • Heat intolerance Increased thirst Sweating Weight loss Menustrual irregularities Emotional liability Shortness of breath Fatigue Prominent eyes Diarrhoea Goitre Hair loss and pruritus

SIGNS • Tremor • Warm moist skin • Tachycardia, AF, widened pulse pressure •

SIGNS • Tremor • Warm moist skin • Tachycardia, AF, widened pulse pressure • Heart failure • Myopathy(proximal) • Hyper active tendon reflexes

FEATURES SPECIFIC TO GRAVES DISEASE Thyrotoxicosis Exophthalmos Goitre Classical triad

FEATURES SPECIFIC TO GRAVES DISEASE Thyrotoxicosis Exophthalmos Goitre Classical triad

Other features Onycholysis(thyroid acropathy) Hair loss Pretibial myxoedema Gynaecomastia Audible bruit

Other features Onycholysis(thyroid acropathy) Hair loss Pretibial myxoedema Gynaecomastia Audible bruit

THYROID OPHTHALMOPATHY • Spasm of upper eyelid with retraction and lid lag • External

THYROID OPHTHALMOPATHY • Spasm of upper eyelid with retraction and lid lag • External ophthalmoplegia • Exophthalmos with proptosis • Supra orbital and infraorbital swelling • Congestion and oedema of conjunctiva

Pathogenesis • cross-reaction of the thyroid antigen and ocular muscle antibodies is apossible explanation

Pathogenesis • cross-reaction of the thyroid antigen and ocular muscle antibodies is apossible explanation

Histologically, • Diffuse lymphocytic infiltration of the retro-orbital tissues occurs, • Fibroblast activation with

Histologically, • Diffuse lymphocytic infiltration of the retro-orbital tissues occurs, • Fibroblast activation with glycosaminoglycan (a mucopolysaccharide) production leading to edema and fibrosis.

OPHTHALMOPATHY Protrusion opthalmoplegia (elevators are involved) {severe} diplopia Optic n. damage blindness (decreasing visual

OPHTHALMOPATHY Protrusion opthalmoplegia (elevators are involved) {severe} diplopia Optic n. damage blindness (decreasing visual acuity Impaired colour vision) MALIGNANT EXOPHTHALMOS

Exophthalmos…. . • result of increased retro-orbital tissue • assessed with an exophthalmometer (Hertel),

Exophthalmos…. . • result of increased retro-orbital tissue • assessed with an exophthalmometer (Hertel), [which measures the distance from the lateral bony orbital margin to the anterior surface of the cornea. ]

DIAGNOSIS A cost-effective work-up can include • extensive history • physical examination, Thyroid function

DIAGNOSIS A cost-effective work-up can include • extensive history • physical examination, Thyroid function tests. • elevated levels of T 3 and T 4 , • a decreased or undetectable level of TSH should be demonstrated.

DIAGNOSIS (CONTD. ) • Thyroid antibodies are elevated • A I 123 radionuclide scan

DIAGNOSIS (CONTD. ) • Thyroid antibodies are elevated • A I 123 radionuclide scan demonstrate diffuse uptake throughout an enlarged gland. • An ultrasound or computed tomography (CT) scan of the neck may be used to evaluate clinical landmarks).

TREATMENT STRATEGIES • Reducing functional mass of thyroid tissue by removal of large part

TREATMENT STRATEGIES • Reducing functional mass of thyroid tissue by removal of large part of the gland • Destruction of most of the gland by I 131 • Anti thyroid drugs to decrease seretion • Drugs that block beta adrenergic receptors

ANTI THYROID DRUGS • PROPYL THIOURACIL • METHIMAZOLE , CARBIMAZOLE • MECH. OF ACTION

ANTI THYROID DRUGS • PROPYL THIOURACIL • METHIMAZOLE , CARBIMAZOLE • MECH. OF ACTION • Inhibit organic binding of thyroid iodine and also inhibit coupling • PTU also inhibit peripheral conversion of T 4 to T 3 • PTU is said to decrease thyroid antibody level

SIDE EFFECT • Rash, fever , peripheral neuritis, polyarteritis, granulocyt openia, agranulocytosis, arthritis liver

SIDE EFFECT • Rash, fever , peripheral neuritis, polyarteritis, granulocyt openia, agranulocytosis, arthritis liver dysfuction PREGNANCY • Drug cross plancetae and also secreted in breast milk – PTU is preferred drug

DOSE • PTU 100 -300 mg tds • Methimazole 1030 mg tds ; then

DOSE • PTU 100 -300 mg tds • Methimazole 1030 mg tds ; then OD

BETA BLOCKERS • Hyperdynamic adrenergic effect of thyrotoxicosis are alleviated. • Decrease peripheral conversion

BETA BLOCKERS • Hyperdynamic adrenergic effect of thyrotoxicosis are alleviated. • Decrease peripheral conversion • Reduce heart rate , control tremor , agitation • Not effective as sole mean of therapy as hyper metabolism and weight loss continue • Usually preferred - propranalol • May ppt heart failure and asthma

RESULTS • Improved symptom by 2 wks • Euthyriod by 6 wks • Given

RESULTS • Improved symptom by 2 wks • Euthyriod by 6 wks • Given 12 – 18 months [relapse 50%] • Thyroxine can be added to prevent hypothyroidism

RADIOACTIVE IODINE SUITABLE PATIENT • Small or medium sized goitre • Relapse after medical

RADIOACTIVE IODINE SUITABLE PATIENT • Small or medium sized goitre • Relapse after medical or surgical therapy • Contraindication to antithyriod drug or surgery

CONTRAINDICATION ABSOUTE • Pregnancy • Breast feeding RELATIVE • Thyroid opthalmopathy • Isolated thyroid

CONTRAINDICATION ABSOUTE • Pregnancy • Breast feeding RELATIVE • Thyroid opthalmopathy • Isolated thyroid nodule • Toxic nodular goitre • Young age

ADMINISTRATION • Should be euthyroid before I 131 • Stop all anti thyroid drugs

ADMINISTRATION • Should be euthyroid before I 131 • Stop all anti thyroid drugs 2 -3 wks prior for uptake • A drink of I 131 sodium iodide • Initial dose is about 10 mci of I 131

ADMINISTRATION • After std. treatment- euthyroid within 2 months. Some become hypothyroid • Long

ADMINISTRATION • After std. treatment- euthyroid within 2 months. Some become hypothyroid • Long term follow up –hypothyroidism and recc. Hyperthyroidism may aggravate ophthalmopathy

COMPLICATIONS • Exacerbation of thyrotoxicosis • Overt thyroid storm • Hypothyroidism • Risk of

COMPLICATIONS • Exacerbation of thyrotoxicosis • Overt thyroid storm • Hypothyroidism • Risk of foetal damage in pregnancy • Worsening of eye signs • Hyperparathyroidism

ADVANTAGES • Avoidance of surgery DIADVANTAGES • Hypothyroidism • Overall treatment cost is less

ADVANTAGES • Avoidance of surgery DIADVANTAGES • Hypothyroidism • Overall treatment cost is less • Adverse effect on opthalmopathy • Treatment ease Reccurent thyrotoxicosis is managed by radioiodine because reoperation carries higher morbidity

SURGERY INDICATIONS • Intolerance or non compliance with anti thyroid drugs • When radioiodine

SURGERY INDICATIONS • Intolerance or non compliance with anti thyroid drugs • When radioiodine is contraindicated • Young patients • Graves optthalmopathy

Indications(contd. ) • Pregnancy • suspicious nodule in graves glands • Large toxic nodular

Indications(contd. ) • Pregnancy • suspicious nodule in graves glands • Large toxic nodular goitre with low I 131 uptake • Very large goitre and severe thyrotoxicosis at initial presentation

RISKS • R. L. N. injury • Hypoparathyroidism • Permanent hypothyroidism

RISKS • R. L. N. injury • Hypoparathyroidism • Permanent hypothyroidism

PREOPERATIVE PREPERATION • Thyrotoxicosis is controlled medically -better nutritional state - provides normal homeostatic

PREOPERATIVE PREPERATION • Thyrotoxicosis is controlled medically -better nutritional state - provides normal homeostatic mechanisms and responses to stress of operation • Wait for 2 months after euthyroid-other wise more chance for thyroid storm • Treated with lugols iodine for 10 days prior to operation to decrease the vascularity of the gland

Preferred surgery TOTAL THYROIDECTOMY • Low chance for relapse but more chance for nerve

Preferred surgery TOTAL THYROIDECTOMY • Low chance for relapse but more chance for nerve damage and hypoparathyroidism SUBTOTAL AND NEAR TOTAL THYROIDECTOMY • Higher chance for relapse lesser complications

COMPLICATION • • • Hoarseness of voice Hypoparathyroidism Infection Air embolism Thyroid storm

COMPLICATION • • • Hoarseness of voice Hypoparathyroidism Infection Air embolism Thyroid storm

ADVANTAGES • Immediate cure • Decreased long term incidence of hypothyroidism • Decreased op

ADVANTAGES • Immediate cure • Decreased long term incidence of hypothyroidism • Decreased op visits • Potential removal of a carcinoma DISADVANTAGES • All complications • Haematoma • Hypertrophic scar

TREATMENT OF EXOPTHALMOS • Severity is independent of thyrotoxicosis • Treatment is directed to

TREATMENT OF EXOPTHALMOS • Severity is independent of thyrotoxicosis • Treatment is directed to prevent infection and reduce periorbital swelling • High dose systemic corticosteroid (prednisolone 60 mg) • Retrobulbar injection of depot steroids

 • SURGICAL INTERVENTIONS • Lateral tarsoraphy • Orbital decompression • Cryosurgical rduction of

• SURGICAL INTERVENTIONS • Lateral tarsoraphy • Orbital decompression • Cryosurgical rduction of pituitary OTHERS • Radiation therapy with steroids • Plasma exchange therapy • Immunosupppressants-cyclosporine, azathioprine

THYROID STORM • Rarely during thyroidal or other surgery PRECIPITATING FACTORS • Infection, labour,

THYROID STORM • Rarely during thyroidal or other surgery PRECIPITATING FACTORS • Infection, labour, administaration of iodine, after treatment with I 131

 • MANIFESTATIONS • Hyperthermia, tachycardia, intense irritability, profuse sweating, hypertension, extreme anxiety, prostration,

• MANIFESTATIONS • Hyperthermia, tachycardia, intense irritability, profuse sweating, hypertension, extreme anxiety, prostration, hypotension and death • All are adrenergic phenomenon • Caused by adrenergic outburst in a sensitised patient by thyroid hormone induction

MANGEMENT • Best management –prophylaxis • Patients with toxicity should be made euthyroid before

MANGEMENT • Best management –prophylaxis • Patients with toxicity should be made euthyroid before operation. TREATMENT • Fluid replacement • Lugols iodine • Hydrocortisone (cortisol beakdown is increased) • Cooling blanket avoid aspirin

 • Reserpine and guanethidine (sympatholytic treatment) • Oxygen • Glucose infusion

• Reserpine and guanethidine (sympatholytic treatment) • Oxygen • Glucose infusion

SUMMARY • Thyrotoxicosis can be primary or secondary • Graves disease is the most

SUMMARY • Thyrotoxicosis can be primary or secondary • Graves disease is the most common type • It is an autoimmune disorder • Classical triad – goitre, thyrotoxicois, exophthalmos • Investigations-T 3 , T 4, TSH, thyroid antibodies

 • Treatment options are –drugs, radioactive iodine, surgery • Over 45: radioiodine. Under

• Treatment options are –drugs, radioactive iodine, surgery • Over 45: radioiodine. Under 45: surgery for the large goitre, antithyroid drugs for the small goitre. • Thyroid storm is an adrenergic outburst in a sensitised patient which is better prevented than treated